Verification and Extension of the Glasgow Western Infirmary based Theory of Limited Acute Appendicitis using a Nigerian Hospital
Research Progress of Spironolactone as an Antagonist of NRG1-ERBB4 Pathway in the Treatment of Cognitive Impairment in Schizophrenia